Talis Biomedical CorpOTC Pink - Current Information:TLIS
- LAST PRICE1.8500
- TODAY'S CHANGE (%)0.1300 (7.5581%)
- Bid / Lots1.8000/ 1
- Ask / Lots1.8800/ 1
- Open / Previous Close1.8800 / 1.7200
- Day Range
- 52 Week Range
- Volume12,007
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TLIS |
|---|---|---|
| 09:33 ET | 1380 | 1.9 |
| 10:45 ET | 600 | 1.81 |
| 10:54 ET | 246 | 1.72 |
| 11:18 ET | 134 | 1.77 |
| 11:57 ET | 147 | 1.76 |
| 12:26 ET | 373 | 1.77 |
| 01:27 ET | 8220 | 1.85 |
| 01:29 ET | 800 | 1.85 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Talis Biomedical Corp | 3.4M | -0.1x | --- |
Helix BioMedix Inc | 3.4M | -1.0x | --- |
Seelos Therapeutics Inc | 235.5K | 0.0x | --- |
Drazcanna Inc | 164.2K | 0.0x | --- |
Aeolus Pharmaceuticals Inc | 150.0 | 0.0x | --- |
Adynxx Inc | 580.0 | 0.0x | --- |
Company Information
Talis Biomedical Corporation is a molecular diagnostic company. The Company is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
Contact Information
- Headquarters
- 1375 West Fulton Market, Suite 700CHICAGO, IL, United States 60607
- Phone
- 650-433-3000
- Fax
- 302-636-5454
Executives
- Chief Executive Officer, Director
- Robert Kelley
- Co-Founder, Director
- Rustem Ismagilov
- Interim Chief Financial Officer
- Rebecca Markovich
- Lead Independent Director
- Kimberly Popovits
- Director
- Raymond Cheong
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4M |
|---|---|
Revenue (TTM) | $408.0K |
Shares Outstanding | 1.8M |
Talis Biomedical Corp does not pay a dividend. | |
Beta | 1.60 |
EPS | $-28.02 |
Book Value | $37.93 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 8.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,510.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
